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There are many established and hypothesised interactions
between cells in the microenvironment of haematopoietic and
lymphatic systems (Torok-Storb, 1988). It is well known that
bone marrow stromal cells play a critical role in homing,
growth and differentiation of haematopoietic progenitor cells
(Harigaya et al., 1981; Harigaya & Handu, 1985; Zipori &
Sasson, 1980; Hunt et al., 1987; Whitlock et al., 1987).
Similarly, thymic epithelial cells modulate the proliferation
and differentiation of thymic lymphocytes (Snodgrass, 1985;
Ezink et al., 1984). As for lymph nodes, considerable
research has been directed toward dendritic cells which act as
antigen-presenting cells or accessary cells in the initiation of
T cell-dependent immune responses (Steinman & Witmer,
1978; Schrader & Nossal, 1980; Tew et al., 1982). However,
little consideration has been given to the possibility that
lymph node stromal cells control the proliferation of lym-
phocytes. The objective of this study was to clarify the
presence of cellular interaction between lymph node stromal
cells and lymphoid leukaemia cells which affects the growth
of the leukaemic cells.
Lymph node stromal cells were derived from a cervical
lymph node which had been biopsied for diagnosis from a
patient with non-Hodgkin's lymphoma (NHL). They were
cultured in RPMI-1640 medium with penicillin, streptomycin
and 5% fetal bovine serum for 2 months with seven passages,
and stored in liquid nitrogen until use. Before each experi-
ment, cells were thawed and recultured for 1-2 months with
three to eight passages. With more than 10 passages in total,
only uniform adherent cells were being cultured and these
cells were used as LNST cells in the study. They were charac-
terised cytochemically by the presence of a-naphthyl butyrate
esterase and ASD-chloroacetate esterase activity, and no
myeloperoxydase activity. Flow cytometric analysis of their
surface phenotype showed that 42%, 65% and 58% of the
cells were positive for CDllb, CD36 and HLA-DR, respec-
tively.
The diagnosis of patients (six adult T-cell leukaemia (ATL)
of chronic type, two T-chronic lymphocytic leukaemia (T-
CLL), one B-CLL and one leukaemic conversion of NHL)
were based on accepted clinical, haematological and
laboratory findings. Immunofluorescent analysis of the sur-
face phenotype using a flow cytometer (Tsuda & Takatsuki,
1984) revealed that ATL cells expressed CD2+, 3+, 4+, 8-,
T-CLL CD2+, 3+, 4-, 8+, and B-CLL CDl9+, 20+, A+, k+,
and NHL CDl9+, 20+, pi, A+. Peripheral blood
mononuclear cells (PBM) from patients were separated from
heparinised blood by Ficoll-Conray density gradient centri-
fugation. Separated PBM contained more than 85% malig-
nant cells as assessed by surface phenotype analysis, and used
as leukaemic cells in the study.
LNST cells and leukaemia cells were cocultured as follows.
LNST cells were seeded at 1 x 104 cells per 200 ll per well in
96-well flat bottomed culture plates. Then leukaemia cells
were overlaid at 2 x I05 cells per 200I.I per well on LNST
cells when the latter became confluent. After 72 h of co-
culture, cells were pulsed with 1 gLCi 3H-thymidine (3H-TdR)
for 15 h, detached from the plates by treatment with trypsin-
EDTA (Sigma, St Louis, MO, USA) and harvested for
measurement of 3H-TdR uptake. Incorporation of 3H-TdR
by leukaemic cells was calculated by subtracting c.p.m. of
LNST cell culture from c.p.m. of co-culture.
The results of the co-culture experiment are shown in
Figure 1. In 4/6 ATL (ATL 1, 2, 4 and 6), 1/2 T-CLL
(T-CLL 1) and 2/2 B cell malignancies, a dramatic increase in
3H-TdR uptake by leukaemia cells was observed. On the
other hand, 2/6 ATL (ATL 3 and 5), 1/2 T-CLL (T-CLL 2)
showed an apparent decrease in 3H-TdR uptake.
LNST cells could exert their effect by direct cell-to-cell
contact and/or soluble factors. To dissect these mechanisms
of action, the influence of fixation of LNST cells on their
effect was studied first. Before co-culture, LNST cells were
treated with 2.5% glutaraldehyde for 5 min at 37°C, and
washed five times with culture medium. As shown in Figure
1, these fixed LNST cells inhibited the 3H-TdR uptake of all
the leukaemia cells tested.
Next, the effect of conditioned medium from LNST cells
(LNST-CM) on leukaemia cell growth was examined.
Confluent LNST cells were cultured for 4 days and the
cell-free culture medium was used as LNST-CM. Figure 2
shows that LNST-CM dose-dependently enhanced the 3H-
TdR uptake of leukaemia cells in 5/5 ATL (ATL 1, 2, 4, 5
and 6), but not in 1/1 T-CLL (T-CLL 1) and 2/2 B cell
malignancies, although the patterns of dose-response curves
varied from patient to patient. It should be noted that this
observed enhancement of 3H-TdR incorporation is not as
marked as seen in the co-culture experiment.
These data suggest that proliferation of lymphoid
leukaemia cells is under dual control by LNST cells:
negatively by cell-to-cell contact and positively by soluble
factors. Recently, it has been reported that lymph node
stromal cells exert similar effects on lymphoid cell lines
(Ohkawa et al., 1989). The proliferation of a T-acute
lymphoblastic leukaemia (T-ALL) line and a B-ALL line was
inhibited by co-cultivation with stromal cells, and stromal
cell-CM enhanced the growth of only a T-ALL line.
Although the present data from primary culture of leukaemia
cells support those observations, our study implies the
existence of the other components in culture which positively
control the leukaemia cell growth besides the soluble factors
in LNST-CM, since CM alone could not reconstitute the
marked growth promoting effect of stromal cells seen in
co-culture experiment (Figure I and 2). This effect could be
achieved via cell-to-cell contact or contact through the extra-
cellular matrix (ECM) as has been shown in immature
haematopoietic cells and stromal cells in bone marrow (Gor-
don et al., 1989; Gallagher & Dexter, 1989); an effect which
is lost after glutaraldehyde treatment of LNST cells. The
LNST cells used in this study are phenotypically
heterogenous. Therefore complicated control of leukaemia
cell growth could be accomplished by different types of
stromal cells. Characterisation of cloned LNST cells is now
under study.
The variety of the expression of surface molecules on the
leukaemia cells which are involved in cell-to-cell and factor-
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Figure 1 Effect of LNST cells on the uptake of 3H-TdR by lymphoid leukaemia cells. Leukaemia cells were cultured alone (open
columns) or on the monolayer of live (hatched columns) or glutaraldehyde-fixed (filled columns) LNST cells. Three days later, cells
were pulsed with 3H-TdR for 15 h, detached from culture plates and harvested for the measurement of 3H-TdR uptake. 3H-TdR
uptake by leukaemia cells was calculated by subtracting c.p.m. of cultures of live or fixed LNST cells alone from c.p.m. of
co-cultures. The results are presented as the mean of triplicate cultures ± standard deviation (s.d.). *P<0.01, **P<0.05 when
compared with result with cultures of leukaemia cells alone.
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to-cell signalling may determine their own growth in vitro.
The basic abnormality in CLL, the proliferation or
accumulation of abnormal lymphocytes in the lymph nodes,
bone marrow and spleen, varies considerably in severity from
patient to patient, and the course of the disease ranges from
nearly acute to almost completely benign (Rundles, 1977).
The same is true for ATL, which is clinically classified into
acute, chronic, smouldering and lymphoma types (Kawano et
al., 1985). Therefore, even in vivo, the reactivity to positive
and negative controls by stromal cells in each organ may
influence the clinical manifestation of the diseases. Analysis
of soluble factors and molecules on cell surface or in the
ECM which are involved in leukaemia cell-stromal cell
interaction should lead to an understanding of
pathophysiology of lymphoid cell growth and accumulation
in lymph nodes.
Figure 2 Effect of LNST-CM on the uptake of 3H-TdR by
lymphoid leukaemia cells. Leukaemia cells were cultured in the
presence of various concentrations of LNST-CM. Methods are
described in detail in the text and in the legend for Figure 1.
Each point represents the mean of triplicate cultures. The s.d. of
each point was always less than 5%.
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